In accordance, depletion of CD8+ T cells in syngeneic mice treated with combination therapy precluded EMT6 tumor eradication (Fig. 7b and Supplementary Fig. 7) and survival benefit (Fig. 7c). Here, CD8A is linked to neoplasm.